IMI2 – Call 12

IMI2 - Call 12 was launched on 19 July 2017 with the following topics:

  • Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD)
  • FAIRification of IMI and EFPIA data
  • Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS)
  • European Health Data Network (EHDN)
  • Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations
  • Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolic diseases
  • European Screening Centre: unique library for attractive biology (ESCulab)

More information on the topics can be found in IMI’s press release and in the the Call text. Other relevant documents can be found on the IMI2 Call documents page.


The projects resulting from IMI2 - Call 12 are:

  • EHDEN - Electronic health data in a European network
    factsheet | website
  • ESCulab - European screening centre; unique library for attractive biology
    factsheet | website
  • FAIRplus - FAIRplus
    factsheet | website
  • IM2PACT - Investigating mechanisms and models predictive of accessibility of therapeutics (IM2PACT) into the brain
    factsheet | website
  • NECESSITY - New clinical endpoints in primary Sjögren’s Syndrome: an interventional trial based on stratifying patients
    factsheet | website
  • RADAR-AD - Remote assessment of disease and relapse – Alzheimer’s disease
    factsheet | website
  • VITAL - Vaccines and infectious diseases in the ageing population
    factsheet | website


Call statistics

  • Proposals submitted: 29
  • Inadmissible & ineligible proposals: 1
  • Proposals recommended for funding: 7
  • Proposals not recommended for funding: 21